首页 > 最新文献

BMC Clinical Pathology最新文献

英文 中文
Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer. 单羧酸盐转运体 1(MCT1)是子宫内膜癌独立的预后生物标志物。
Q2 Medicine Pub Date : 2017-12-28 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0067-7
Ayşe Latif, Amy L Chadwick, Sarah J Kitson, Hannah J Gregson, Vanitha N Sivalingam, James Bolton, Rhona J McVey, Stephen A Roberts, Kay M Marshall, Kaye J Williams, Ian J Stratford, Emma J Crosbie

Background: Endometrial cancer (EC) is a major health concern due to its rising incidence. Whilst early stage disease is generally cured by surgery, advanced EC has a poor prognosis with limited treatment options. Altered energy metabolism is a hallmark of malignancy. Cancer cells drive tumour growth through aerobic glycolysis and must export lactate to maintain intracellular pH. The aim of this study was to evaluate the expression of the lactate/proton monocarboxylate transporters MCT1 and MCT4 and their chaperone CD147 in EC, with the ultimate aim of directing future drug development.

Methods: MCT1, MCT4 and CD147 expression was examined using immunohistochemical analysis in 90 endometrial tumours and correlated with clinico-pathological characteristics and survival outcomes.

Results: MCT1 and MCT4 expression was observed in the cytoplasm, the plasma membrane or both locations. CD147 was detected in the plasma membrane and associated with MCT1 (p = 0.003) but not with MCT4 (p = 0.207) expression. High MCT1 expression was associated with reduced overall survival (p = 0.029) and remained statistically significant after adjustment for survival covariates (p = 0.017).

Conclusion: Our data suggest that MCT1 expression is an important marker of poor prognosis in EC. MCT1 inhibition may have potential as a treatment for advanced or recurrent EC.

背景:子宫内膜癌(EC)的发病率不断上升,已成为人们关注的主要健康问题。虽然早期疾病一般可通过手术治愈,但晚期子宫内膜癌的预后较差,治疗方案有限。能量代谢改变是恶性肿瘤的标志。癌细胞通过有氧糖酵解驱动肿瘤生长,并必须输出乳酸以维持细胞内的 pH 值。本研究旨在评估乳酸/质子一羧酸盐转运体MCT1和MCT4及其伴侣CD147在EC中的表达,最终目的是指导未来的药物开发:方法:采用免疫组化分析方法检测90例子宫内膜肿瘤中MCT1、MCT4和CD147的表达情况,并将其与临床病理特征和生存结果相关联:结果:观察到MCT1和MCT4在细胞质、质膜或两个位置均有表达。在质膜上检测到 CD147,它与 MCT1(p = 0.003)的表达有关,但与 MCT4(p = 0.207)的表达无关。MCT1的高表达与总生存率降低有关(p = 0.029),在调整生存协变量后仍具有统计学意义(p = 0.017):我们的数据表明,MCT1表达是EC预后不良的重要标志。结论:我们的数据表明,MCT1表达是EC预后不良的重要标志物,抑制MCT1可能具有治疗晚期或复发性EC的潜力。
{"title":"Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer.","authors":"Ayşe Latif, Amy L Chadwick, Sarah J Kitson, Hannah J Gregson, Vanitha N Sivalingam, James Bolton, Rhona J McVey, Stephen A Roberts, Kay M Marshall, Kaye J Williams, Ian J Stratford, Emma J Crosbie","doi":"10.1186/s12907-017-0067-7","DOIUrl":"10.1186/s12907-017-0067-7","url":null,"abstract":"<p><strong>Background: </strong>Endometrial cancer (EC) is a major health concern due to its rising incidence. Whilst early stage disease is generally cured by surgery, advanced EC has a poor prognosis with limited treatment options. Altered energy metabolism is a hallmark of malignancy. Cancer cells drive tumour growth through aerobic glycolysis and must export lactate to maintain intracellular pH. The aim of this study was to evaluate the expression of the lactate/proton monocarboxylate transporters MCT1 and MCT4 and their chaperone CD147 in EC, with the ultimate aim of directing future drug development.</p><p><strong>Methods: </strong>MCT1, MCT4 and CD147 expression was examined using immunohistochemical analysis in 90 endometrial tumours and correlated with clinico-pathological characteristics and survival outcomes.</p><p><strong>Results: </strong>MCT1 and MCT4 expression was observed in the cytoplasm, the plasma membrane or both locations. CD147 was detected in the plasma membrane and associated with MCT1 (<i>p</i> = 0.003) but not with MCT4 (<i>p</i> = 0.207) expression. High MCT1 expression was associated with reduced overall survival (<i>p</i> = 0.029) and remained statistically significant after adjustment for survival covariates (<i>p</i> = 0.017).</p><p><strong>Conclusion: </strong>Our data suggest that MCT1 expression is an important marker of poor prognosis in EC. MCT1 inhibition may have potential as a treatment for advanced or recurrent EC.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"27"},"PeriodicalIF":0.0,"publicationDate":"2017-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745908/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35706523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impending relapse of myelodysplastic syndrome after allogeneic transplant is difficult to diagnose and requires a multi-modal approach. 同种异体移植后骨髓增生异常综合征的复发是难以诊断的,需要多模式的方法。
Q2 Medicine Pub Date : 2017-12-28 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0066-8
Elizabeth L Courville, Megan Griffith, Celalettin Ustun, Sophia Yohe, Erica Warlick

Background: The only potentially curative therapy for myelodysplastic syndrome is allogeneic hematopoietic cell transplant; unfortunately, there is a high relapse rate. The objective of this study was to perform a detailed clinicopathologic study of patients with relapsed myeloid neoplasm following allogeneic hematopoietic cell transplant for myelodysplastic syndrome.

Methods: Pre-transplant, post-transplant, and relapse bone marrow and peripheral blood morphologic features (including dysplasia) were retrospectively evaluated by study authors. Clinical features and results of cytogenetic analysis and engraftment/chimerism studies were obtained from the medical record.

Results: Our study describes 21 patients with a median time to relapse of 6 months (range 2-82). Ten of the patients relapsed with higher grade disease, including six with overt acute myeloid leukemia. Pre-transplant megakaryocyte dysplasia was associated with dysplastic megakaryocytes in the relapse specimen; however, neither erythroid dysplasia nor granulocytic dysplasia were associated with their counterpart in the relapse specimen. Relapse specimens had a lower marrow cellularity and higher blast percentage than pre-transplant disease. Cytogenetic comparisons before and after transplant showed variety, including clonal evolution (22%), the same abnormal clone (33%), or a different abnormal clone (22%).

Conclusions: Our detailed review of post-transplant marrow biopsies prior to relapse highlights the difficulty in diagnosing relapse and particularly impending relapse.

背景:唯一可能治愈骨髓增生异常综合征的治疗方法是异体造血细胞移植;不幸的是,复发率很高。本研究的目的是对骨髓增生异常综合征的异基因造血细胞移植后复发的髓系肿瘤患者进行详细的临床病理研究。方法:研究作者回顾性评价移植前、移植后和复发时骨髓和外周血形态学特征(包括不典型增生)。临床特征和细胞遗传学分析和移植/嵌合研究结果从医疗记录中获得。结果:我们的研究描述了21例中位复发时间为6个月(范围2-82)的患者。10例患者复发为更高级别疾病,包括6例明显急性髓性白血病。移植前巨核细胞发育不良与复发标本中巨核细胞发育不良相关;然而,在复发标本中,红血球发育不良和粒细胞发育不良都与它们的对应物无关。与移植前相比,复发标本的骨髓细胞含量较低,细胞百分比较高。移植前后的细胞遗传学比较显示出多样性,包括克隆进化(22%)、相同的异常克隆(33%)或不同的异常克隆(22%)。结论:我们对复发前移植后骨髓活检的详细回顾强调了诊断复发的困难,特别是即将复发。
{"title":"Impending relapse of myelodysplastic syndrome after allogeneic transplant is difficult to diagnose and requires a multi-modal approach.","authors":"Elizabeth L Courville,&nbsp;Megan Griffith,&nbsp;Celalettin Ustun,&nbsp;Sophia Yohe,&nbsp;Erica Warlick","doi":"10.1186/s12907-017-0066-8","DOIUrl":"https://doi.org/10.1186/s12907-017-0066-8","url":null,"abstract":"<p><strong>Background: </strong>The only potentially curative therapy for myelodysplastic syndrome is allogeneic hematopoietic cell transplant; unfortunately, there is a high relapse rate. The objective of this study was to perform a detailed clinicopathologic study of patients with relapsed myeloid neoplasm following allogeneic hematopoietic cell transplant for myelodysplastic syndrome.</p><p><strong>Methods: </strong>Pre-transplant, post-transplant, and relapse bone marrow and peripheral blood morphologic features (including dysplasia) were retrospectively evaluated by study authors. Clinical features and results of cytogenetic analysis and engraftment/chimerism studies were obtained from the medical record.</p><p><strong>Results: </strong>Our study describes 21 patients with a median time to relapse of 6 months (range 2-82). Ten of the patients relapsed with higher grade disease, including six with overt acute myeloid leukemia. Pre-transplant megakaryocyte dysplasia was associated with dysplastic megakaryocytes in the relapse specimen; however, neither erythroid dysplasia nor granulocytic dysplasia were associated with their counterpart in the relapse specimen. Relapse specimens had a lower marrow cellularity and higher blast percentage than pre-transplant disease. Cytogenetic comparisons before and after transplant showed variety, including clonal evolution (22%), the same abnormal clone (33%), or a different abnormal clone (22%).</p><p><strong>Conclusions: </strong>Our detailed review of post-transplant marrow biopsies prior to relapse highlights the difficulty in diagnosing relapse and particularly impending relapse.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"28"},"PeriodicalIF":0.0,"publicationDate":"2017-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12907-017-0066-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35706524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Elevation of small, dense low density lipoprotein cholesterol-a possible antecedent of atherogenic lipoprotein phenotype in type 2 diabetes patients in Jos, North-Central Nigeria. 尼日利亚中北部乔斯 2 型糖尿病患者体内小而致密的低密度脂蛋白胆固醇升高--这可能是致动脉粥样硬化脂蛋白表型的先兆。
Q2 Medicine Pub Date : 2017-12-06 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0065-9
Kenneth O Inaku, Obasola O Ogunkeye, Fayeofori M Abbiyesuku, Evelyn K Chuhwak, Christian O Isichei, Lucius C Imoh, Noel O Amadu, Alexander O Abu

Background: The global prevalence of type 2 diabetes is increasing. Dyslipidaemia is a known complication of diabetes mellitus manifesting frequently as cardiovascular diseases and stoke. Elevation of small, dense low density lipoprotein has been recognised as a component of the atherogenic lipoprotein phenotype associated with cardiovascular complications. We speculate that the elevation of this lipoprotein particle may be the antecedent of the atherogenic lipoprotein phenotype. This study therefore aims to determine the pattern of dyslipidaemia among diabetes mellitus patients in Jos, North-Central Nigeria.

Methods: One hundred and seventy-six patients with type 2 diabetes and 154 age-matched controls were studied. The patients with diabetes were regular clinic attenders and had stable glycaemic control. None were on lipid-lowering therapy. Anthropometric indices, blood pressure, and lipids (including total cholesterol, high density lipoprotein cholesterol, and triglyceride) were measured by chemical methods using the Hitachi 902 analyzer. Low density lipoprotein cholesterol was calculated using the Friedewald's equation. Small, dense low density lipoprotein cholesterol, -sdLDL-C was measured using the precipitation method by Hirano et al. Means of the different groups were compared using EPI Info and a P-value of <0.05 was accepted as significant difference.

Results: Total cholesterol, low density lipoprotein cholesterol, triglyceride and small, dense lipoprotein cholesterol were all significantly higher in diabetes patients than controls except high density lipoprotein cholesterol. The percentage of LDL-C as sdLDL-C among the diabetes versus control group was 45% ± 17.79 v 32.0% ± 15.93. Serum sdLDL-C concentration was determined to be 1.45 ± 0.64 among diabetes patients and 0.8 ± 0.54 among control subjects. 75% of diabetes patients had hypertension and were taking blood pressure lowering medications.

Conclusion: The classical atherogenic lipoprotein phenotype was not demonstrated among subjects with type 2 diabetes mellitus in this study, but the elevation of serum small dense low density lipoprotein cholesterol in patients with sustained hypertension suggests the establishment of atherogenic complications among our diabetes patients.

背景:全球 2 型糖尿病的发病率正在上升。众所周知,血脂异常是糖尿病的一种并发症,经常表现为心血管疾病和脑卒中。小而致密的低密度脂蛋白的升高已被认为是与心血管并发症相关的致动脉粥样硬化脂蛋白表型的一个组成部分。我们推测,这种脂蛋白颗粒的升高可能是致动脉粥样硬化脂蛋白表型的先兆。因此,本研究旨在确定尼日利亚中北部乔斯糖尿病患者的血脂异常模式:研究对象包括 176 名 2 型糖尿病患者和 154 名年龄匹配的对照者。糖尿病患者定期就诊,血糖控制稳定。他们都没有接受降脂治疗。人体测量指数、血压和血脂(包括总胆固醇、高密度脂蛋白胆固醇和甘油三酯)均使用日立 902 分析仪,通过化学方法进行测量。低密度脂蛋白胆固醇用弗里德瓦尔德方程计算。使用 EPI 信息和 P 值比较不同组的平均值:除高密度脂蛋白胆固醇外,糖尿病患者的总胆固醇、低密度脂蛋白胆固醇、甘油三酯和小致密脂蛋白胆固醇均明显高于对照组。糖尿病组与对照组的低密度脂蛋白胆固醇(sdLDL-C)百分比分别为 45% ± 17.79 对 32.0% ± 15.93。经测定,糖尿病患者的血清 sdLDL-C 浓度为 1.45 ± 0.64,对照组为 0.8 ± 0.54。75%的糖尿病患者患有高血压,并正在服用降压药:结论:本研究中,2 型糖尿病患者中并未出现典型的致动脉粥样硬化脂蛋白表型,但持续高血压患者血清小致密低密度脂蛋白胆固醇的升高表明,糖尿病患者中存在致动脉粥样硬化并发症。
{"title":"Elevation of small, dense low density lipoprotein cholesterol-a possible antecedent of atherogenic lipoprotein phenotype in type 2 diabetes patients in Jos, North-Central Nigeria.","authors":"Kenneth O Inaku, Obasola O Ogunkeye, Fayeofori M Abbiyesuku, Evelyn K Chuhwak, Christian O Isichei, Lucius C Imoh, Noel O Amadu, Alexander O Abu","doi":"10.1186/s12907-017-0065-9","DOIUrl":"10.1186/s12907-017-0065-9","url":null,"abstract":"<p><strong>Background: </strong>The global prevalence of type 2 diabetes is increasing. Dyslipidaemia is a known complication of diabetes mellitus manifesting frequently as cardiovascular diseases and stoke. Elevation of small, dense low density lipoprotein has been recognised as a component of the atherogenic lipoprotein phenotype associated with cardiovascular complications. We speculate that the elevation of this lipoprotein particle may be the antecedent of the atherogenic lipoprotein phenotype. This study therefore aims to determine the pattern of dyslipidaemia among diabetes mellitus patients in Jos, North-Central Nigeria.</p><p><strong>Methods: </strong>One hundred and seventy-six patients with type 2 diabetes and 154 age-matched controls were studied. The patients with diabetes were regular clinic attenders and had stable glycaemic control. None were on lipid-lowering therapy. Anthropometric indices, blood pressure, and lipids (including total cholesterol, high density lipoprotein cholesterol, and triglyceride) were measured by chemical methods using the Hitachi 902 analyzer. Low density lipoprotein cholesterol was calculated using the Friedewald's equation. Small, dense low density lipoprotein cholesterol, -sdLDL-C was measured using the precipitation method by Hirano et al. Means of the different groups were compared using EPI Info and a <i>P</i>-value of <0.05 was accepted as significant difference.</p><p><strong>Results: </strong>Total cholesterol, low density lipoprotein cholesterol, triglyceride and small, dense lipoprotein cholesterol were all significantly higher in diabetes patients than controls except high density lipoprotein cholesterol. The percentage of LDL-C as sdLDL-C among the diabetes versus control group was 45% ± 17.79 v 32.0% ± 15.93. Serum sdLDL-C concentration was determined to be 1.45 ± 0.64 among diabetes patients and 0.8 ± 0.54 among control subjects. 75% of diabetes patients had hypertension and were taking blood pressure lowering medications.</p><p><strong>Conclusion: </strong>The classical atherogenic lipoprotein phenotype was not demonstrated among subjects with type 2 diabetes mellitus in this study, but the elevation of serum small dense low density lipoprotein cholesterol in patients with sustained hypertension suggests the establishment of atherogenic complications among our diabetes patients.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"26"},"PeriodicalIF":0.0,"publicationDate":"2017-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718080/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35327503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic accuracy of touch imprint cytology for head and neck malignancies: a useful intra-operative tool in resource limited countries. 触摸印迹细胞学诊断头颈部恶性肿瘤的准确性:在资源有限的国家一个有用的术中工具。
Q2 Medicine Pub Date : 2017-11-25 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0063-y
Hania Naveed, Mariam Abid, Atif Ali Hashmi, Muhammad Muzammamil Edhi, Ahmareen Khalid Sheikh, Ghazala Mudassir, Amir Khan

Background: Intraoperative consultation is an important tool for the evaluation of the upper aerodigestive tract (UAT) malignancies. Although frozen section analysis is a preferred method of intra-operative consultation, however in resource limited countries like Pakistan, this facility is not available in most institutes; therefore, we aimed to evaluate the diagnostic accuracy of touch imprint cytology for UAT malignancies using histopathology of the same tissue as gold standard.

Methods: The study involved 70 cases of UAT lesions operated during the study period. Intraoperatively, after obtaining the fresh biopsy specimen and prior to placing them in fixative, each specimen was imprinted on 4-6 glass slides, fixed immediately in 95% alcohol and stained with Hematoxylin and Eosin stain. After completion of the cytological procedure, the surgical biopsy specimen was processed. The slides of both touch Imprint cytology and histopathology were examined by two consultant histopathologists.

Results: The result of touch imprint cytology showed that touch imprint cytology was diagnostic in 68 cases (97.1%), 55 (78.6%) being malignant, 2 cases (2.9%) were suspicious for malignancy, 11 cases (15.7%) were negative for malignancy while 2 cases (2.9%) were false negative. Amongst the 70 cases, 55 cases (78.6%) were malignant showing squamous cell carcinoma in 49 cases (70%), adenoid cystic carcinoma in 2 cases (2.9%), non-Hodgkin lymphoma 2 cases (2.9%), Mucoepidermoid carcinoma 1 case (1.4%), spindle cell sarcoma in 1 case (1.4%). Two cases (2.9%) were suspicious of malignancy showing atypical squamoid cells on touch imprint cytology, while 13 cases (18.6%) were negative for malignancy, which also included 2 false negative cases. The overall diagnostic accuracy of touch imprint cytology came out to be 96.7% with a sensitivity and specificity of 96 and 100%, respectively while PPV and NPV of touch imprint cytology was found to be 100 and 84%, respectively.

Conclusion: Our experience in this study has demonstrated that touch imprint cytology provides reliable specific diagnoses and can be used as an adjunct to histopathology, particularly in developing countries, where the facility of frozen section is often not available, since a rapid preliminary diagnosis may help in the surgical management planning.

背景:术中会诊是评估上消化道(UAT)恶性肿瘤的重要手段。虽然冷冻切片分析是术中会诊的首选方法,但在资源有限的国家,如巴基斯坦,大多数机构都没有这种设施;因此,我们的目的是评估触摸印迹细胞学对UAT恶性肿瘤的诊断准确性,使用相同组织的组织病理学作为金标准。方法:选取研究期间手术的70例UAT病变。术中,在获得新鲜活检标本后,将标本置于固定液中,将每个标本印迹在4-6张载玻片上,立即用95%酒精固定,并用苏木精和伊红染色。细胞学检查完成后,对手术活检标本进行处理。两名组织病理学顾问检查了触摸印迹细胞学和组织病理学切片。结果:触摸印迹细胞学检查结果显示,触摸印迹细胞学诊断68例(97.1%),恶性55例(78.6%),可疑恶性2例(2.9%),恶性阴性11例(15.7%),假阴性2例(2.9%)。70例中,恶性55例(78.6%),其中鳞状细胞癌49例(70%),腺样囊性癌2例(2.9%),非霍奇金淋巴瘤2例(2.9%),粘液表皮样癌1例(1.4%),梭形细胞肉瘤1例(1.4%)。2例(2.9%)触印细胞学检查表现为非典型鳞状细胞,怀疑为恶性,13例(18.6%)为恶性阴性,其中假阴性2例。触觉印迹细胞学的总体诊断准确率为96.7%,灵敏度和特异性分别为96%和100%,触觉印迹细胞学的PPV和NPV分别为100%和84%。结论:我们在这项研究中的经验表明,触摸印迹细胞学提供了可靠的特异性诊断,可以作为组织病理学的辅助,特别是在发展中国家,那里通常没有冷冻切片设备,因为快速的初步诊断可能有助于手术管理计划。
{"title":"Diagnostic accuracy of touch imprint cytology for head and neck malignancies: a useful intra-operative tool in resource limited countries.","authors":"Hania Naveed,&nbsp;Mariam Abid,&nbsp;Atif Ali Hashmi,&nbsp;Muhammad Muzammamil Edhi,&nbsp;Ahmareen Khalid Sheikh,&nbsp;Ghazala Mudassir,&nbsp;Amir Khan","doi":"10.1186/s12907-017-0063-y","DOIUrl":"https://doi.org/10.1186/s12907-017-0063-y","url":null,"abstract":"<p><strong>Background: </strong>Intraoperative consultation is an important tool for the evaluation of the upper aerodigestive tract (UAT) malignancies. Although frozen section analysis is a preferred method of intra-operative consultation, however in resource limited countries like Pakistan, this facility is not available in most institutes; therefore, we aimed to evaluate the diagnostic accuracy of touch imprint cytology for UAT malignancies using histopathology of the same tissue as gold standard.</p><p><strong>Methods: </strong>The study involved 70 cases of UAT lesions operated during the study period. Intraoperatively, after obtaining the fresh biopsy specimen and prior to placing them in fixative, each specimen was imprinted on 4-6 glass slides, fixed immediately in 95% alcohol and stained with Hematoxylin and Eosin stain. After completion of the cytological procedure, the surgical biopsy specimen was processed. The slides of both touch Imprint cytology and histopathology were examined by two consultant histopathologists.</p><p><strong>Results: </strong>The result of touch imprint cytology showed that touch imprint cytology was diagnostic in 68 cases (97.1%), 55 (78.6%) being malignant, 2 cases (2.9%) were suspicious for malignancy, 11 cases (15.7%) were negative for malignancy while 2 cases (2.9%) were false negative. Amongst the 70 cases, 55 cases (78.6%) were malignant showing squamous cell carcinoma in 49 cases (70%), adenoid cystic carcinoma in 2 cases (2.9%), non-Hodgkin lymphoma 2 cases (2.9%), Mucoepidermoid carcinoma 1 case (1.4%), spindle cell sarcoma in 1 case (1.4%). Two cases (2.9%) were suspicious of malignancy showing atypical squamoid cells on touch imprint cytology, while 13 cases (18.6%) were negative for malignancy, which also included 2 false negative cases. The overall diagnostic accuracy of touch imprint cytology came out to be 96.7% with a sensitivity and specificity of 96 and 100%, respectively while PPV and NPV of touch imprint cytology was found to be 100 and 84%, respectively.</p><p><strong>Conclusion: </strong>Our experience in this study has demonstrated that touch imprint cytology provides reliable specific diagnoses and can be used as an adjunct to histopathology, particularly in developing countries, where the facility of frozen section is often not available, since a rapid preliminary diagnosis may help in the surgical management planning.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"25"},"PeriodicalIF":0.0,"publicationDate":"2017-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12907-017-0063-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35309205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Lymphoepithelial carcinoma: a case report of a rare tumor of the larynx. 淋巴上皮癌:喉部罕见肿瘤的病例报告。
Q2 Medicine Pub Date : 2017-11-25 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0061-0
Nawal Hammas, Najib Benmansour, Mohamed Nour-Dine El Alami El Amine, Laila Chbani, Hind El Fatemi

Background: Lymphoepithelial carcinoma is a tumor mostly diagnosed in the nasopharynx, but it has also been described in a variety of nonnasopharyngeal sites. It is extremely rare in the larynx and should be distinguished from squamous cell carcinoma. Therefore, it must be known by clinicians, pathologists and oncologists. In this case report, we discuss its etiopathogeny, its epidemiological, clinical, pathological and therapeutic aspects, and its outcome.

Case presentation: An 81-year-old Morrocan man, smoker for 40 years, presented with a 1 year history of dysphonia, dyspnea and dysphagia. Laryngoscopy showed a mass occupying supraglottic, glottic and subglottic levels of the larynx. Cervico-thoracic computed tomography scan showed a laryngeal wall thickening with cervical lymphadenopathy. Laryngeal biopsy was performed. Microscopic analysis and immunohistochemistry confirmed the diagnosis of laryngeal lymphoepithelial carcinoma. Immunostaining for LMP1 was negative.

Conclusion: Laryngeal lymphoepithelial carcinoma is an extremely rare and an aggressive tumor. It is rarely associated with the EBV. It must be regarded as a distinct entity. Radiotherapy is advisable as the unique therapy for local tumor. A correct diagnosis and a close collaboration between the pathologist and clinicians is mandatory for an optimal treatment strategy.

背景:淋巴上皮癌是一种主要在鼻咽部确诊的肿瘤,但在非鼻咽部的多个部位也有发生。喉部淋巴上皮癌极为罕见,应与鳞状细胞癌区分开来。因此,临床医生、病理学家和肿瘤学家必须了解这种疾病。在本病例报告中,我们将讨论其病因、流行病学、临床、病理和治疗方面及其结果:一名 81 岁的摩洛哥男子,吸烟 40 年,出现发音障碍、呼吸困难和吞咽困难病史 1 年。喉镜检查显示,喉部声门上、声门和声门下有肿块。颈胸计算机断层扫描显示喉壁增厚并伴有颈淋巴结病。进行了喉活检。显微镜分析和免疫组化证实了喉淋巴上皮癌的诊断。LMP1免疫染色呈阴性:结论:喉淋巴上皮癌是一种极其罕见的侵袭性肿瘤。结论:喉淋巴上皮癌是一种极其罕见的侵袭性肿瘤,很少与 EB 病毒相关。必须将其视为一个独特的实体。放疗是治疗局部肿瘤的唯一方法。正确的诊断以及病理学家和临床医生之间的密切合作是最佳治疗策略的必要条件。
{"title":"Lymphoepithelial carcinoma: a case report of a rare tumor of the larynx.","authors":"Nawal Hammas, Najib Benmansour, Mohamed Nour-Dine El Alami El Amine, Laila Chbani, Hind El Fatemi","doi":"10.1186/s12907-017-0061-0","DOIUrl":"10.1186/s12907-017-0061-0","url":null,"abstract":"<p><strong>Background: </strong>Lymphoepithelial carcinoma is a tumor mostly diagnosed in the nasopharynx, but it has also been described in a variety of nonnasopharyngeal sites. It is extremely rare in the larynx and should be distinguished from squamous cell carcinoma. Therefore, it must be known by clinicians, pathologists and oncologists. In this case report, we discuss its etiopathogeny, its epidemiological, clinical, pathological and therapeutic aspects, and its outcome.</p><p><strong>Case presentation: </strong>An 81-year-old Morrocan man, smoker for 40 years, presented with a 1 year history of dysphonia, dyspnea and dysphagia. Laryngoscopy showed a mass occupying supraglottic, glottic and subglottic levels of the larynx. Cervico-thoracic computed tomography scan showed a laryngeal wall thickening with cervical lymphadenopathy. Laryngeal biopsy was performed. Microscopic analysis and immunohistochemistry confirmed the diagnosis of laryngeal lymphoepithelial carcinoma. Immunostaining for LMP1 was negative.</p><p><strong>Conclusion: </strong>Laryngeal lymphoepithelial carcinoma is an extremely rare and an aggressive tumor. It is rarely associated with the EBV. It must be regarded as a distinct entity. Radiotherapy is advisable as the unique therapy for local tumor. A correct diagnosis and a close collaboration between the pathologist and clinicians is mandatory for an optimal treatment strategy.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"24"},"PeriodicalIF":0.0,"publicationDate":"2017-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702189/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35309204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Solitary fibrous tumor occurring in the parotid gland: a case report. 孤立性纤维性肿瘤发生于腮腺:1例报告。
Q2 Medicine Pub Date : 2017-11-21 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0062-z
Meryem Rais, Amine Kessab, Zahra Sayad, Sanae El Mourabit, Redallah Zrarqi, Salma Benazzou, Malik Boulaadas, Nadia Cherradi

Background: Solitary fibrous tumor is an uncommon spindle cell neoplasm of unknown origin. It has been reported in many anatomic sites, with a rare occurrence in the head and neck region. Solitary fibrous tumors of the parotid gland are exceptional; their clinical and radiologic features are non specific, often mimicking more common salivary gland tumors. Pathologic examination and immunohistochemistry are required to make the correct diagnosis. The prognosis is favorable, with most tumors being benign, and complete surgical resection is the treatment of choice.

Case presentation: We report the case of a 42-year-old man who presented with a painless mass involving the parotid gland. A parotidectomy was performed, and follow up was unremarkable. Gross examination showed a well circumscribed, firm tumor measuring 3,4 cm. Histologically, the tumor was composed of a spindle cell proliferation of variable cellularity, with staghorn vessels. A panel of immunohistochemical stains was performed, and confirmed the diagnosis of parotid gland solitary fibrous tumor.

Conclusion: In this report we aim to increase awareness of this rare entity among clinicians and pathologists, and to emphasize the role of immunohistochemistry in confirming the diagnosis.

背景:孤立性纤维性肿瘤是一种少见的来源不明的梭形细胞肿瘤。它已在许多解剖部位报道,罕见的发生在头颈部区域。孤立的腮腺纤维性肿瘤是例外;它们的临床和放射学特征是非特异性的,通常与更常见的唾液腺肿瘤相似。正确的诊断需要病理检查和免疫组织化学。预后良好,大多数肿瘤是良性的,完全手术切除是治疗的选择。病例介绍:我们报告的情况下,一个42岁的男子谁提出了一个无痛性肿块涉及腮腺。行腮腺切除术,随访无显著差异。大体检查显示一个界限清楚、结实的肿瘤,直径为3,4厘米。组织学上,肿瘤由可变细胞的梭形细胞增生组成,有鹿角状血管。经免疫组化染色证实为腮腺孤立性纤维性肿瘤。结论:在本报告中,我们旨在提高临床医生和病理学家对这种罕见实体的认识,并强调免疫组织化学在确诊中的作用。
{"title":"Solitary fibrous tumor occurring in the parotid gland: a case report.","authors":"Meryem Rais,&nbsp;Amine Kessab,&nbsp;Zahra Sayad,&nbsp;Sanae El Mourabit,&nbsp;Redallah Zrarqi,&nbsp;Salma Benazzou,&nbsp;Malik Boulaadas,&nbsp;Nadia Cherradi","doi":"10.1186/s12907-017-0062-z","DOIUrl":"https://doi.org/10.1186/s12907-017-0062-z","url":null,"abstract":"<p><strong>Background: </strong>Solitary fibrous tumor is an uncommon spindle cell neoplasm of unknown origin. It has been reported in many anatomic sites, with a rare occurrence in the head and neck region. Solitary fibrous tumors of the parotid gland are exceptional; their clinical and radiologic features are non specific, often mimicking more common salivary gland tumors. Pathologic examination and immunohistochemistry are required to make the correct diagnosis. The prognosis is favorable, with most tumors being benign, and complete surgical resection is the treatment of choice.</p><p><strong>Case presentation: </strong>We report the case of a 42-year-old man who presented with a painless mass involving the parotid gland. A parotidectomy was performed, and follow up was unremarkable. Gross examination showed a well circumscribed, firm tumor measuring 3,4 cm. Histologically, the tumor was composed of a spindle cell proliferation of variable cellularity, with staghorn vessels. A panel of immunohistochemical stains was performed, and confirmed the diagnosis of parotid gland solitary fibrous tumor.</p><p><strong>Conclusion: </strong>In this report we aim to increase awareness of this rare entity among clinicians and pathologists, and to emphasize the role of immunohistochemistry in confirming the diagnosis.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"22"},"PeriodicalIF":0.0,"publicationDate":"2017-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12907-017-0062-z","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35306126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Posterior cerebral fossa medulloepithelioma: report of a case. 脑后窝髓样上皮瘤1例报告。
Q2 Medicine Pub Date : 2017-11-21 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0064-x
Nezha Oumghar, Fatima Ezzahra Hazmiri, Abdelhamid El Omrani, Hanane Rais, Mouna Khouchani

Background: Medulloepithelioma is a rare primitive neuroectodermal tumor of the central nervous system, usually developing in childhood. Due to its rarity, the optimal management is still unknown. The prognosis is poor, especially when resection is incomplete. Adjuvant radiochemotherapy is often indicated.

Case presentation: We report a rare case of infratentorial medulloepithelioma in a 3 year old girl. She presented symptoms of increased intracranial pressure. On examination, she had coordination problems, ptosis and exotropia of the right eye. Magnetic resonance imaging demonstrated a large cerebellar vermix tumor. Immuno-histochemistry revealed a diffuse positivity for Vimentin and focal positivity for the epithelial membrane antigen, but Glial Fibrillary Acidic Protein and Synaptophysin were negative, the MIB-1 antibody was very high. She received postoperative craniospinal irradiation and died 7 months later.

Conclusion: We describe the features (epidemiological, clinical, histological, immunohistochemical and therapeutic outcomes) of our case and confront it to literature data.

背景:髓样上皮瘤是一种罕见的中枢神经系统原始神经外胚层肿瘤,通常发生于儿童期。由于其稀缺性,其最优管理仍然是未知的。预后较差,尤其是切除不完全时。通常需要辅助放化疗。病例介绍:我们报告一个罕见的3岁女孩幕下髓样上皮瘤病例。她表现出颅内压升高的症状经检查,她有协调问题,上睑下垂和右眼外斜视。磁共振成像显示一个大的小脑混合瘤。免疫组化示Vimentin弥漫性阳性,上皮膜抗原局灶性阳性,胶质纤维酸性蛋白和Synaptophysin阴性,抗体mb -1高。术后接受颅脊髓放射治疗,7个月后死亡。结论:我们描述了本病例的特征(流行病学、临床、组织学、免疫组织化学和治疗结果),并与文献资料进行了对比。
{"title":"Posterior cerebral fossa medulloepithelioma: report of a case.","authors":"Nezha Oumghar,&nbsp;Fatima Ezzahra Hazmiri,&nbsp;Abdelhamid El Omrani,&nbsp;Hanane Rais,&nbsp;Mouna Khouchani","doi":"10.1186/s12907-017-0064-x","DOIUrl":"https://doi.org/10.1186/s12907-017-0064-x","url":null,"abstract":"<p><strong>Background: </strong>Medulloepithelioma is a rare primitive neuroectodermal tumor of the central nervous system, usually developing in childhood. Due to its rarity, the optimal management is still unknown. The prognosis is poor, especially when resection is incomplete. Adjuvant radiochemotherapy is often indicated.</p><p><strong>Case presentation: </strong>We report a rare case of infratentorial medulloepithelioma in a 3 year old girl. She presented symptoms of increased intracranial pressure. On examination, she had coordination problems, ptosis and exotropia of the right eye. Magnetic resonance imaging demonstrated a large cerebellar vermix tumor. Immuno-histochemistry revealed a diffuse positivity for Vimentin and focal positivity for the epithelial membrane antigen, but Glial Fibrillary Acidic Protein and Synaptophysin were negative, the MIB-1 antibody was very high. She received postoperative craniospinal irradiation and died 7 months later.</p><p><strong>Conclusion: </strong>We describe the features (epidemiological, clinical, histological, immunohistochemical and therapeutic outcomes) of our case and confront it to literature data.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"23"},"PeriodicalIF":0.0,"publicationDate":"2017-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12907-017-0064-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35306127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a case report and literature review. 新发急性淋巴细胞白血病样疾病伴MYC和BCL2和/或BCL6重排的高级别b细胞淋巴瘤:1例报告和文献复习
Q2 Medicine Pub Date : 2017-11-09 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0060-1
Akiko Uchida, Yasushi Isobe, Yu Uemura, Yuji Nishio, Hirotaka Sakai, Masayuki Kato, Kaori Otsubo, Masahiro Hoshikawa, Masayuki Takagi, Ikuo Miura

Background: B-cell lymphomas harboring the 8q24/MYC plus 18q21/BCL2 translocations are now referred to as high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements (HGBL-MBR). Although HGBL-MBR is frequently found in cases with diffuse large B-cell lymphoma or Burkitt lymphoma-like B-cell lymphoma, acute lymphoblastic leukemia (ALL)-like disease of HGBL-MBR (AL-HGBL-MBR) has been reported incidentally.

Case presentation: A 69-year-old Japanese woman developed remittent fever and increasing systemic bone pain. The bone marrow examination revealed that more than 90% of nuclear cells were blastoid cells, which were positive for CD10, CD19, CD20, and surface IgMκ and negative for terminal deoxynucleotidyl transferase (TdT). Cytogenetic studies confirmed that the patient had de novo AL-HGBL-MBR with the extra copies of MYC and loss of chromosome 17p. She showed resistance to chemoimmunotherapy and died seven months after the diagnosis. The literature review identified further 47 de novo AL-HGBL-MBR cases within the last 32 years. The median age was 61 years (range, 27 - 86); the male/female ratio was 2.0. Thirty-eight cases (79%) presented a clinical picture of ALL at diagnosis; 14 (36%) of 39 available cases showed central nervous system involvement. Loss of 17p and translocations at 2p12-13, 3q27, 9p13 were frequently observed as additional cytogenetic abnormalities. Although the median survival of 46 available cases was only five months (range, 0.1-18), rituximab use significantly improved the survival of AL-HGBL-MBR (log-rank test, P = 0.0294).

Conclusion: Our patient and most reported de novo AL-HGBL-MBR cases showed resistance to conventional chemoimmunotherapy and disastrous consequences. AL-HGBL-MBL is a rare, but should be considered a distinct clinical condition in HGBL-MBR. Other therapeutic strategies, such as using inhibitors of MYC and BCL2, are needed to overcome the chemoresistance of AL-HGBL-MBR.

背景:含有8q24/MYC + 18q21/BCL2易位的b细胞淋巴瘤现在被称为MYC、BCL2和/或BCL6重排的高级别b细胞淋巴瘤(HGBL-MBR)。虽然HGBL-MBR常见于弥漫性大b细胞淋巴瘤或伯基特淋巴瘤样b细胞淋巴瘤,但HGBL-MBR的急性淋巴细胞白血病(ALL)样疾病(AL-HGBL-MBR)也有偶然报道。病例介绍:一名69岁的日本妇女出现了散热和全身骨痛。骨髓检查显示90%以上的核细胞为囊胚样细胞,CD10、CD19、CD20和表面IgMκ阳性,末端脱氧核苷酸转移酶(TdT)阴性。细胞遗传学研究证实,该患者患有新发AL-HGBL-MBR,伴有MYC的额外拷贝和17p染色体的缺失。她对化学免疫疗法表现出耐药性,在确诊后7个月死亡。文献回顾在过去的32年中发现了另外47例AL-HGBL-MBR新发病例。中位年龄为61岁(27 - 86岁);男女比例为2.0。38例(79%)在诊断时表现为ALL的临床表现;39例病例中有14例(36%)显示中枢神经系统受累。17p缺失和2p12-13、3q27、9p13的易位经常被观察到为额外的细胞遗传学异常。虽然46例可用病例的中位生存期仅为5个月(范围0.1-18),但使用利妥昔单抗可显著提高AL-HGBL-MBR的生存期(log-rank检验,P = 0.0294)。结论:我们的患者和大多数报道的新发AL-HGBL-MBR病例对常规化疗免疫治疗具有耐药性和灾难性后果。AL-HGBL-MBL是一种罕见的,但应被视为HGBL-MBR的独特临床状况。其他治疗策略,如使用MYC和BCL2抑制剂,需要克服AL-HGBL-MBR的化疗耐药。
{"title":"De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> rearrangements: a case report and literature review.","authors":"Akiko Uchida,&nbsp;Yasushi Isobe,&nbsp;Yu Uemura,&nbsp;Yuji Nishio,&nbsp;Hirotaka Sakai,&nbsp;Masayuki Kato,&nbsp;Kaori Otsubo,&nbsp;Masahiro Hoshikawa,&nbsp;Masayuki Takagi,&nbsp;Ikuo Miura","doi":"10.1186/s12907-017-0060-1","DOIUrl":"https://doi.org/10.1186/s12907-017-0060-1","url":null,"abstract":"<p><strong>Background: </strong>B-cell lymphomas harboring the 8q24/<i>MYC</i> plus 18q21/<i>BCL2</i> translocations are now referred to as high grade B-cell lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> rearrangements (HGBL-MBR). Although HGBL-MBR is frequently found in cases with diffuse large B-cell lymphoma or Burkitt lymphoma-like B-cell lymphoma, acute lymphoblastic leukemia (ALL)-like disease of HGBL-MBR (AL-HGBL-MBR) has been reported incidentally.</p><p><strong>Case presentation: </strong>A 69-year-old Japanese woman developed remittent fever and increasing systemic bone pain. The bone marrow examination revealed that more than 90% of nuclear cells were blastoid cells, which were positive for CD10, CD19, CD20, and surface IgMκ and negative for terminal deoxynucleotidyl transferase (TdT). Cytogenetic studies confirmed that the patient had de novo AL-HGBL-MBR with the extra copies of <i>MYC</i> and loss of chromosome 17p. She showed resistance to chemoimmunotherapy and died seven months after the diagnosis. The literature review identified further 47 de novo AL-HGBL-MBR cases within the last 32 years. The median age was 61 years (range, 27 - 86); the male/female ratio was 2.0. Thirty-eight cases (79%) presented a clinical picture of ALL at diagnosis; 14 (36%) of 39 available cases showed central nervous system involvement. Loss of 17p and translocations at 2p12-13, 3q27, 9p13 were frequently observed as additional cytogenetic abnormalities. Although the median survival of 46 available cases was only five months (range, 0.1-18), rituximab use significantly improved the survival of AL-HGBL-MBR (log-rank test, <i>P</i> = 0.0294).</p><p><strong>Conclusion: </strong>Our patient and most reported de novo AL-HGBL-MBR cases showed resistance to conventional chemoimmunotherapy and disastrous consequences. AL-HGBL-MBL is a rare, but should be considered a distinct clinical condition in HGBL-MBR. Other therapeutic strategies, such as using inhibitors of MYC and BCL2, are needed to overcome the chemoresistance of AL-HGBL-MBR.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"21"},"PeriodicalIF":0.0,"publicationDate":"2017-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12907-017-0060-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35259780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Primary hyperoxaluria detected by bone marrow biopsy: case report. 骨髓活检检测原发性高血氧血症1例。
Q2 Medicine Pub Date : 2017-09-20 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0059-7
F Nachite, M Dref, A Fakhri, H Rais

Background: Primary hyperoxaluria is a rare disease with an estimated prevalence of 1 to 3 cases per million. It is due to a hepatic enzyme deficiency responsible for an endogenous overproduction of oxalate. Oxalate crystals commonly deposit in the kidney and more rarely in bone marrow. The literature has reported, to the best of our knowledge, only two cases of hyperoxaluria diagnosed by bone marrow biopsy and our case is the only one that does not show radiological bone lesions.

Case presentation: A young 22 year old chronic hemodialysis patient with nephrocalcinosis. The patient had a personal and family history of recurrent kidney stones. He presented bone pain with worsening of his general state. On physical examination, no organomegaly was detected. Biological check-up showed only a normochromic and normocytic regenerative anemia resistant to treatment and a bone marrow biopsy was performed. It showed deposits of crystals of oxalate in the bone marrow surrounded by inflammatory reaction against foreign bodies. Given our context, no liver biopsy or genetic studies, which are gold standard of diagnosis testing, were done. The diagnosis of primary hyperoxaluria was made based on morphological characteristics of crystals, his medical and family history, and the absence of any secondary cause of the condition. Since curative treatment is not available in our country, the patient only receives a palliative treatment.

Conclusion: Primary hyperoxaluria is rarely evoked by the histological study of a bone marrow biopsy. The lack of the possibility of the only effective treatment in our context and the diagnosis, usually late, of this pathology are at the origin of the fatal evolution of the disease in almost all the cases.

背景:原发性高草酸尿症是一种罕见的疾病,估计患病率为百万分之1至3例。这是由于肝酶缺乏负责内源性草酸过量生产。草酸盐晶体通常沉积在肾脏中,很少在骨髓中。文献报道,据我们所知,只有两例高草酸尿通过骨髓活检诊断,我们的病例是唯一一个没有显示放射骨病变的病例。病例介绍:一位22岁的慢性血液透析患者并发肾钙质沉着症。患者有复发性肾结石的个人和家族病史。他表现为骨痛,全身状况恶化。体格检查未见器官肿大。生物检查显示仅为对治疗有抵抗力的正色和正细胞再生贫血,并进行了骨髓活检。骨髓中有草酸盐结晶沉积,周围有抵抗异物的炎症反应。鉴于我们的背景,没有进行肝活检或基因研究,而这是诊断测试的金标准。原发性高草酸尿的诊断是基于晶体的形态特征,他的医疗和家族史,以及没有任何继发原因。由于在我国没有治愈性治疗,病人只能接受姑息治疗。结论:原发性高草酸尿很少由骨髓活检组织学研究引起。在我们的情况下,缺乏唯一有效治疗的可能性,并且通常很晚才诊断出这种病理,这是几乎所有病例中疾病致命演变的根源。
{"title":"Primary hyperoxaluria detected by bone marrow biopsy: case report.","authors":"F Nachite,&nbsp;M Dref,&nbsp;A Fakhri,&nbsp;H Rais","doi":"10.1186/s12907-017-0059-7","DOIUrl":"https://doi.org/10.1186/s12907-017-0059-7","url":null,"abstract":"<p><strong>Background: </strong>Primary hyperoxaluria is a rare disease with an estimated prevalence of 1 to 3 cases per million. It is due to a hepatic enzyme deficiency responsible for an endogenous overproduction of oxalate. Oxalate crystals commonly deposit in the kidney and more rarely in bone marrow. The literature has reported, to the best of our knowledge, only two cases of hyperoxaluria diagnosed by bone marrow biopsy and our case is the only one that does not show radiological bone lesions.</p><p><strong>Case presentation: </strong>A young 22 year old chronic hemodialysis patient with nephrocalcinosis. The patient had a personal and family history of recurrent kidney stones. He presented bone pain with worsening of his general state. On physical examination, no organomegaly was detected. Biological check-up showed only a normochromic and normocytic regenerative anemia resistant to treatment and a bone marrow biopsy was performed. It showed deposits of crystals of oxalate in the bone marrow surrounded by inflammatory reaction against foreign bodies. Given our context, no liver biopsy or genetic studies, which are gold standard of diagnosis testing, were done. The diagnosis of primary hyperoxaluria was made based on morphological characteristics of crystals, his medical and family history, and the absence of any secondary cause of the condition. Since curative treatment is not available in our country, the patient only receives a palliative treatment.</p><p><strong>Conclusion: </strong>Primary hyperoxaluria is rarely evoked by the histological study of a bone marrow biopsy. The lack of the possibility of the only effective treatment in our context and the diagnosis, usually late, of this pathology are at the origin of the fatal evolution of the disease in almost all the cases.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"20"},"PeriodicalIF":0.0,"publicationDate":"2017-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12907-017-0059-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35443754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Biochemical and histological alterations induced by the smoke of allethrin based mosquito coil on mice model. 丙烯菊酯蚊香烟雾致小鼠生化及组织学改变。
Q2 Medicine Pub Date : 2017-08-30 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0057-9
M Abdulla Al-Mamun, M Ataur Rahman, M Habibur Rahman, K M F Hoque, Z Ferdousi, Mohammad Nurul Matin, M Abu Reza

Background: Mosquito coil (MC) emits insecticide upon burning which provides limited protection against lethal mosquito borne diseases. However, apart from killing the insect, toxicities associated with the inhalation of these insecticides poses severe health hazards. However, the use of MC is increasing day by day in third world countries in particular but, yet to receive enough attention of both policy maker and general public. The current study was aimed to assess the MC smoke induced damage of pulmonary and hepatic tissues along with observing the alterations of several blood biochemical parameters in mice model.

Methods: A total of twenty four Swiss albino mice were allowed to inhale the smoke of allethrin based MC at different duration per day for 120 days. By the end of treatment period, blood sample was drawn from each mouse and blood biochemical parameters including alanine transaminase (ALT), aspartate transaminase (AST), blood urea nitrogen(BUN), serum total protein, cholesterol, low density lipoprotein (LDL) and triglyceride (TG) were analyzed. Intact lung and liver were collected for histological analysis using standard protocol.

Results: Biochemical study indicates elevated activity of two hepatic enzymes: ALT (89%), AST (85%), in comparison with the respective control. Increased level of some parameters of lipid profile including cholesterol (36%), LDL (48%) and triglyceride (30%) in smoke inhaled mice is the new finding of this study. On the contrary, the activity of serum total protein and BUN was decreased by 20% and 24%, respectively in inhaled mice. Pulmonary tissue of treated mice shows severe forms of emphysema and hyperplasia, especially in the peripheral region of lung, which is the hallmark of chronic obstructive pulmonary disease (COPD). Histological study of hepatic tissue shows apoptosis mediated damage of hepatocytes along with severe form of necrosis. Infiltration of Inflammatory cells was also observed in both of the organs.

Conclusion: Results from the present studies suggest that chronic exposure of allethrin based MC is responsible factor for severe health complications such as COPD due to the alterations of the key biochemical parameters of blood and histo-organization of lung and liver.

背景:蚊香在燃烧时释放杀虫剂,对致命的蚊媒疾病提供有限的保护。然而,除了杀死昆虫外,与吸入这些杀虫剂有关的毒性对健康造成严重危害。然而,MC的使用日益增加,特别是在第三世界国家,但尚未得到政策制定者和公众的足够重视。本研究旨在通过观察mcc烟雾对小鼠肺和肝组织的损伤以及血液生化指标的改变来评估mcc烟雾对小鼠肺和肝组织的损伤。方法:选取24只瑞士白化小鼠,每天不同时间连续吸入丙烯菊酯基MC烟雾120 d。治疗期结束时,采集各组小鼠血液,分析血清总蛋白、胆固醇、低密度脂蛋白(LDL)、甘油三酯(TG)、谷丙转氨酶(ALT)、谷草转氨酶(AST)、尿素氮(BUN)等血液生化指标。收集完整的肺和肝脏,按照标准方案进行组织学分析。结果:生化研究表明,与对照组相比,ALT(89%)和AST(85%)两种肝酶活性升高。吸烟小鼠血脂参数胆固醇(36%)、低密度脂蛋白(48%)和甘油三酯(30%)升高是本研究的新发现。相反,吸入小鼠血清总蛋白和BUN活性分别降低20%和24%。治疗小鼠的肺组织显示出严重的肺气肿和增生,特别是在肺的外周区域,这是慢性阻塞性肺疾病(COPD)的标志。肝组织组织学研究显示凋亡介导的肝细胞损伤伴严重形式的坏死。两脏器均可见炎性细胞浸润。结论:从目前的研究结果表明,慢性接触丙烯菊酯的MC负责因素严重的并发症如慢性阻塞性肺病由于改变的关键生化参数的血液和histo-organization肺和肝。
{"title":"Biochemical and histological alterations induced by the smoke of allethrin based mosquito coil on mice model.","authors":"M Abdulla Al-Mamun,&nbsp;M Ataur Rahman,&nbsp;M Habibur Rahman,&nbsp;K M F Hoque,&nbsp;Z Ferdousi,&nbsp;Mohammad Nurul Matin,&nbsp;M Abu Reza","doi":"10.1186/s12907-017-0057-9","DOIUrl":"https://doi.org/10.1186/s12907-017-0057-9","url":null,"abstract":"<p><strong>Background: </strong>Mosquito coil (MC) emits insecticide upon burning which provides limited protection against lethal mosquito borne diseases. However, apart from killing the insect, toxicities associated with the inhalation of these insecticides poses severe health hazards. However, the use of MC is increasing day by day in third world countries in particular but, yet to receive enough attention of both policy maker and general public. The current study was aimed to assess the MC smoke induced damage of pulmonary and hepatic tissues along with observing the alterations of several blood biochemical parameters in mice model.</p><p><strong>Methods: </strong>A total of twenty four Swiss albino mice were allowed to inhale the smoke of allethrin based MC at different duration per day for 120 days. By the end of treatment period, blood sample was drawn from each mouse and blood biochemical parameters including alanine transaminase (ALT), aspartate transaminase (AST), blood urea nitrogen(BUN), serum total protein, cholesterol, low density lipoprotein (LDL) and triglyceride (TG) were analyzed. Intact lung and liver were collected for histological analysis using standard protocol.</p><p><strong>Results: </strong>Biochemical study indicates elevated activity of two hepatic enzymes: ALT (89%), AST (85%), in comparison with the respective control. Increased level of some parameters of lipid profile including cholesterol (36%), LDL (48%) and triglyceride (30%) in smoke inhaled mice is the new finding of this study. On the contrary, the activity of serum total protein and BUN was decreased by 20% and 24%, respectively in inhaled mice. Pulmonary tissue of treated mice shows severe forms of emphysema and hyperplasia, especially in the peripheral region of lung, which is the hallmark of chronic obstructive pulmonary disease (COPD). Histological study of hepatic tissue shows apoptosis mediated damage of hepatocytes along with severe form of necrosis. Infiltration of Inflammatory cells was also observed in both of the organs.</p><p><strong>Conclusion: </strong>Results from the present studies suggest that chronic exposure of allethrin based MC is responsible factor for severe health complications such as COPD due to the alterations of the key biochemical parameters of blood and histo-organization of lung and liver.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"19"},"PeriodicalIF":0.0,"publicationDate":"2017-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12907-017-0057-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35316709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
期刊
BMC Clinical Pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1